BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34130851)

  • 1. Imaging After Locoregional Therapy for Hepatocellular Carcinoma With Emphasis on LIRADS Treatment Response Assessment Criteria.
    Bajaj G; Sundaram K; Jambhekar K; Ram R
    Semin Ultrasound CT MR; 2021 Aug; 42(4):390-404. PubMed ID: 34130851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment Criteria.
    Bajaj G; Sundaram K; Jambhekar K; Ram R
    Semin Ultrasound CT MR; 2021 Aug; 42(4):318-331. PubMed ID: 34130846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Organ Procurement and Transplantation Network hepatocellular carcinoma classification: Alignment with Liver Imaging Reporting and Data System, current gaps, and future direction.
    Kierans AS; Chernyak V; Mendiratta-Lala M; Sirlin CB; Hecht EM; Fowler KJ
    Liver Transpl; 2023 Feb; 29(2):206-216. PubMed ID: 36097856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LI-RADS: Past, Present, and Future, From the
    Marks RM; Masch WR; Chernyak V
    AJR Am J Roentgenol; 2021 Feb; 216(2):295-304. PubMed ID: 33052720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.
    Kielar A; Fowler KJ; Lewis S; Yaghmai V; Miller FH; Yarmohammadi H; Kim C; Chernyak V; Yokoo T; Meyer J; Newton I; Do RK
    Abdom Radiol (NY); 2018 Jan; 43(1):218-230. PubMed ID: 28780679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.
    Kierans AS; Song C; Gavlin A; Roudenko A; Lu L; Askin G; Hecht EM
    AJR Am J Roentgenol; 2020 Nov; 215(5):1085-1092. PubMed ID: 32877248
    [No Abstract]   [Full Text] [Related]  

  • 7. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.
    Elsayes KM; Kielar AZ; Elmohr MM; Chernyak V; Masch WR; Furlan A; Marks RM; Cruite I; Fowler KJ; Tang A; Bashir MR; Hecht EM; Kamaya A; Jambhekar K; Kamath A; Arora S; Bijan B; Ash R; Kassam Z; Chaudhry H; McGahan JP; Yacoub JH; McInnes M; Fung AW; Shanbhogue K; Lee J; Deshmukh S; Horvat N; Mitchell DG; Do RKG; Surabhi VR; Szklaruk J; Sirlin CB
    Abdom Radiol (NY); 2018 Oct; 43(10):2625-2642. PubMed ID: 30155697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.
    An C; Rakhmonova G; Choi JY; Kim MJ
    Clin Mol Hepatol; 2016 Jun; 22(2):296-307. PubMed ID: 27304548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma.
    Tang A; Singal AG; Mitchell DG; Hecht EM; Fowler KJ; Kulik L; Parikh ND; Kono Y; Sirlin CB
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1228-1238. PubMed ID: 30326302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
    Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
    Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2017 Version of LI-RADS for CT and MR Imaging: An Update.
    Elsayes KM; Hooker JC; Agrons MM; Kielar AZ; Tang A; Fowler KJ; Chernyak V; Bashir MR; Kono Y; Do RK; Mitchell DG; Kamaya A; Hecht EM; Sirlin CB
    Radiographics; 2017; 37(7):1994-2017. PubMed ID: 29131761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
    Tang A; Bashir MR; Corwin MT; Cruite I; Dietrich CF; Do RKG; Ehman EC; Fowler KJ; Hussain HK; Jha RC; Karam AR; Mamidipalli A; Marks RM; Mitchell DG; Morgan TA; Ohliger MA; Shah A; Vu KN; Sirlin CB;
    Radiology; 2018 Jan; 286(1):29-48. PubMed ID: 29166245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
    Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.
    Santillan C; Fowler K; Kono Y; Chernyak V
    Abdom Radiol (NY); 2018 Jan; 43(1):75-81. PubMed ID: 28828680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. User and system pitfalls in liver imaging with LI-RADS.
    Elsayes KM; Fowler KJ; Chernyak V; Elmohr MM; Kielar AZ; Hecht E; Bashir MR; Furlan A; Sirlin CB
    J Magn Reson Imaging; 2019 Dec; 50(6):1673-1686. PubMed ID: 31215119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice.
    Delli Pizzi A; Mastrodicasa D; Cianci R; Serafini FL; Mincuzzi E; Di Fabio F; Giammarino A; Mannetta G; Basilico R; Caulo M
    Can Assoc Radiol J; 2021 Nov; 72(4):714-727. PubMed ID: 32436394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Imaging Reporting and Data System Version 2018: Impact on Categorization and Hepatocellular Carcinoma Staging.
    Chernyak V; Flusberg M; Berman J; Fruitman KC; Kobi M; Fowler KJ; Sirlin CB
    Liver Transpl; 2019 Oct; 25(10):1488-1502. PubMed ID: 31344753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
    Seo N; Kim MS; Park MS; Choi JY; Do RKG; Han K; Kim MJ
    Eur Radiol; 2020 Jan; 30(1):261-271. PubMed ID: 31418085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging diagnosis of hepatocellular carcinoma: LI-RADS.
    Cunha GM; Sirlin CB; Fowler KJ
    Chin Clin Oncol; 2021 Feb; 10(1):3. PubMed ID: 32527115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.